All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

287

Reset

287 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • IOV-4001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Unresectable Melanoma, Metastatic Melanoma, Stage III Non-small Cell Lung Cancer

  • IOV-5001Phase 21 trial

    Iovance Biotherapeutics, Inc. · Advanced Solid Tumors, Non-Small Cell Lung Cancer, Triple Negative Breast Cancer (TNBC)

  • IPH5201Phase 21 trial

    Innate Pharma · Non Small Cell Lung Cancer

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • KeynatinibTL007Phase 21 trial

    Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NEO-201Phase 21 trial

    Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer

  • NHT102Phase 21 trial

    Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)

  • OBX-115Phase 21 trial

    Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma

  • OR502Phase 21 trial

    OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm

  • OSE-279Phase 21 trial

    OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)

  • Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer

  • S095018Phase 21 trial

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)

  • S095024Phase 21 trial

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC)

  • SL-28Phase 21 trial

    Second Life Therapeutics · Head & Neck Cancer, Pancreas Carcinoma, Pancreas Cancer, Metastatic

  • ST-067Phase 21 trial

    Simcha IL-18, Inc. · Cancer, Solid Tumor, Melanoma

  • STK-012Phase 21 trial

    Synthekine · Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC

  • STX-241PFL-241Phase 21 trial

    Pierre Fabre Medicament · Non-small Cell Lung Cancer (NSCLC)

  • STX-721PFL-721, EscalatedPhase 21 trial

    Pierre Fabre Medicament · Non-Small Cell Lung Cancer, NSCLC, EGFR/HER2 Exon 20 Insertion Mutation

  • TAS0953HM06Phase 21 trial

    Taiho Pharmaceutical Co., Ltd. · RET-altered Non Small Cell Lung Cancer, RET-altered Solid Tumors

  • TH9619Phase 21 trial

    One-carbon Therapeutics AB · Solid Tumor, Colorectal Cancer (CRC), Squamous Cell Carcinoma of Head and Neck

  • TNG260Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Solid Tumors, Adult, Lung Cancer

  • TNG456Phase 21 trial

    Tango Therapeutics, Inc. · Non Small Cell Lung Cancer, Glioma Glioblastoma Multiforme, Glioma, Malignant

  • TRI-611Phase 21 trial

    TRIANA Biomedicines, Inc. · ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer

  • TT-10Phase 21 trial

    Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer

  • TXN10128Phase 21 trial

    Txinno Bioscience Inc. · NSCLC (Non-small Cell Lung Cancer)

  • VLS-1488Phase 21 trial

    Volastra Therapeutics, Inc. · Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer

  • VMD-928Phase 21 trial

    VM Oncology, LLC · Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer

  • VRN110755Phase 21 trial

    Voronoi, Inc · EGFR-Mutant Non-Small Cell Lung Cancer

  • WEF-001Phase 21 trial

    Auricula Biosciences Inc. · Advanced or Metastatic KRAS-mutant Tumor in Pancreatic Adenocarcinoma, Advanced or Metastatic KRAS-mutant Tumor in Colorectal Cancer, Advanced or Metastatic KRAS-mutant Tumor in Non Small Cell Lung Cancer

  • XTX501Phase 21 trial

    Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

  • XZP-5955Phase 21 trial

    Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • YH42946Phase 21 trial

    Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor

NewerPage 6 of 6

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.